MORABITO, Nunziata
 Distribuzione geografica
Continente #
NA - Nord America 6.561
EU - Europa 4.491
AS - Asia 4.023
SA - Sud America 1.472
AF - Africa 101
OC - Oceania 6
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.658
Nazione #
US - Stati Uniti d'America 6.440
SG - Singapore 1.713
BR - Brasile 1.270
CN - Cina 1.263
IE - Irlanda 1.179
SE - Svezia 1.109
DE - Germania 531
HK - Hong Kong 484
IT - Italia 471
FI - Finlandia 253
VN - Vietnam 207
FR - Francia 171
RU - Federazione Russa 159
UA - Ucraina 151
GB - Regno Unito 142
PL - Polonia 127
IN - India 95
AR - Argentina 72
CA - Canada 62
TR - Turchia 43
EC - Ecuador 42
BE - Belgio 40
MX - Messico 40
NL - Olanda 31
IQ - Iraq 27
ZA - Sudafrica 27
AT - Austria 25
BD - Bangladesh 25
ES - Italia 22
VE - Venezuela 22
JP - Giappone 20
PK - Pakistan 20
UZ - Uzbekistan 18
ID - Indonesia 17
CO - Colombia 16
PY - Paraguay 16
CI - Costa d'Avorio 15
EG - Egitto 14
KR - Corea 14
MA - Marocco 14
CZ - Repubblica Ceca 13
CL - Cile 12
LT - Lituania 11
IL - Israele 10
UY - Uruguay 10
AZ - Azerbaigian 9
AE - Emirati Arabi Uniti 8
JO - Giordania 8
BG - Bulgaria 7
KE - Kenya 7
NO - Norvegia 7
PE - Perù 7
TN - Tunisia 7
AU - Australia 6
CH - Svizzera 6
HN - Honduras 6
KG - Kirghizistan 5
RO - Romania 5
AL - Albania 4
BH - Bahrain 4
BO - Bolivia 4
EE - Estonia 4
KZ - Kazakistan 4
MY - Malesia 4
NG - Nigeria 4
NP - Nepal 4
SN - Senegal 4
BN - Brunei Darussalam 3
BY - Bielorussia 3
DK - Danimarca 3
DO - Repubblica Dominicana 3
DZ - Algeria 3
GE - Georgia 3
GT - Guatemala 3
AM - Armenia 2
BA - Bosnia-Erzegovina 2
CM - Camerun 2
ET - Etiopia 2
GR - Grecia 2
HU - Ungheria 2
IR - Iran 2
JM - Giamaica 2
LU - Lussemburgo 2
LV - Lettonia 2
OM - Oman 2
PA - Panama 2
SA - Arabia Saudita 2
XK - ???statistics.table.value.countryCode.XK??? 2
A2 - ???statistics.table.value.countryCode.A2??? 1
BT - Bhutan 1
BW - Botswana 1
CR - Costa Rica 1
EU - Europa 1
GI - Gibilterra 1
GY - Guiana 1
HR - Croazia 1
LA - Repubblica Popolare Democratica del Laos 1
LB - Libano 1
LK - Sri Lanka 1
MD - Moldavia 1
Totale 16.648
Città #
Dublin 1.179
Chandler 866
Ashburn 812
Singapore 783
Dallas 746
Nyköping 584
Beijing 509
Hong Kong 443
Jacksonville 416
Munich 247
Princeton 215
Dearborn 194
The Dalles 178
Medford 171
Messina 168
Ann Arbor 156
New York 149
Los Angeles 148
Cambridge 131
Des Moines 127
Boardman 116
Warsaw 115
Bremen 105
São Paulo 94
Helsinki 90
Ho Chi Minh City 83
Buffalo 71
Wilmington 61
Jinan 60
Shenyang 60
Tianjin 56
Turku 55
Nanjing 53
Redondo Beach 53
San Mateo 45
Hanoi 44
Rio de Janeiro 42
Moscow 41
Brussels 40
Belo Horizonte 36
Pune 35
Woodbridge 35
Houston 34
Hebei 33
Seattle 32
Frankfurt am Main 31
Guangzhou 31
Curitiba 28
Haikou 28
Catania 27
Zhengzhou 27
Düsseldorf 26
Taizhou 26
Nanchang 25
Ningbo 25
Strasbourg 25
Hangzhou 23
Santa Clara 22
Boston 20
Brooklyn 20
Chicago 20
Brasília 19
Chennai 19
Fuzhou 19
Johannesburg 19
Lancaster 18
Montreal 18
Nuremberg 18
Denver 17
London 17
Poplar 17
Tashkent 17
Porto Alegre 16
Toronto 16
Abidjan 15
Council Bluffs 15
Falls Church 15
Guayaquil 15
Milan 15
Tokyo 15
Fremont 14
Goiânia 14
San Francisco 14
Baghdad 13
Hyderabad 13
Quito 13
Ribeirão Preto 13
Campinas 12
Changsha 12
Orem 12
Osasco 12
Stockholm 12
Taiyuan 12
Amsterdam 11
Atlanta 11
Central 11
Guarulhos 11
Jiaxing 11
Lauterbourg 11
Mexico City 11
Totale 10.678
Nome #
Effects of a long-term treatment with raloxifene on insulin sensitivity in postmenopausal women 238
Anxiety levels predict fracture risk in postmenopausal women assessed for osteoporosis 171
Correction to: Neuropsychological Assessment in Elderly Men with Benign Prostatic Hyperplasia Treated with Dutasteride (Clinical Drug Investigation, (2018), 10.1007/s40261-018-0720-7) 161
Inflammaging and Anti-Inflammaging: The Role of Cytokines in Extreme Longevity 156
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 151
Applicazione quantitativa dell'ultrasonografia ossea quantitativa e dell'Hand grip nello screening per l'osteoporosi e per il rischio di frattura in donne in post-menopausa, condotto con l'algoritmo FRAX 149
Effects of strontium ranelate on bone mass and bone turnover in women with thalassemia major-related osteoporosis 149
Incidence of hypocalcemia and hypercalcemia in hospitalized patients: Is it changing? 149
AB0819 HANDGRIP STRENGTH PREDICTS HIGH FRACTURE RISK IN PATIENTS WITH TYPE 2 DIABETES MELLITUS 146
Anxiety levels predict low bone mineral density in postmenopausal women assessed for osteoporosis. 144
Alexithymia and Psychological Distress Affect Perceived Quality of Life in Patients with Type 2 Diabetes Mellitus 143
ASSOCIAZIONE TRA IMPULSIVITÀ COGNITIVA E DENSITÀ MINERALE OSSEA: STUDIO CROSS-SECTIONAL SU DONNE VALUTATE PER OSTEOPOROSI POSTMENOPAUSALE 142
Anabolic treatment with RHPTH of duchenne muscular dystrophy related osteoporosis: a case report 141
As Time Goes by: Anxiety Negatively Affects the Perceived Quality of Life in Patients With Type 2 Diabetes of Long Duration 140
ASSOCIATION BETWEEN COGNITIVE IMPULSIVITY AND BONE MINERAL DENSITY: A CROSS-SECTIONAL STUDY IN POSTMENOPAUSAL WOMEN EVALUATED FOR OSTEOPOROSIS 138
AB0820 COGNITIVE IMPULSIVITY CORRELATES WITH BONE MINERAL DENSITY 138
ALENDRONATE TAIL EFFECT ON BONE IS MODULATED BY VITAMIN D: A RETROSPECTIVE STUDY IN POSTMENOPAUSAL WOMEN WITH OSTEOPOROSIS 131
Amylasemia in uremics: a complex interpretation 128
BONE MASS AND BONE TURNOVER IN WOMEN WITH THALASSEMIA MAJOR RELATED OSTEOPOROSIS: EFFECTS OF STRONTIUM RANELATE 127
ASSOCIAZIONE TRA LIVELLI DI ANSIA E VITAMINA D IN DONNE IN ETÀ POSTMENOPAUSALE VALUTATE PER OSTEOPOROSI 125
Bisphosphonates in the treatment of thalassemia-induced osteoporosis 124
ANXIETY LEVELS ARE ASSOCIATED WITH FRACTURE RISK IN POSTMENOPAUSAL WOMEN 124
Frailty and lipid profile in elderly hospitalized patients 124
Quality of life and psychological functioning in postmenopausal women undergoing aromatase inhibitor treatment for early breast cancer 124
Wnt antagonist sclerostin and Dickkopf-1 in gestational diabetes 123
Calcifediol improves lipid profile in osteopenic atorvastatin-treated postmenopausal women. 122
PULSED ELECTROMAGNETIC FIELDS AFFECT SCLEROSTIN LEVELS IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 122
Executive functions and bone health: a focus on cognitive impulsivity and bone mineral density 121
Bisphosphonates in the treatment of thalassemia-associated osteoporosis. 120
Bone health assessment by quantitative ultrasound and dual-energy x-ray absorptiometry in postmenopausal women with breast cancer receiving aromatase inhibitors 119
Bone mass and metabolism in patients with myastenia gravis: a possible anabolic role for pyridostigmine on bone tissue 119
Anxiety levels as risk factor for osteoporosis in postmenopausal women 117
Clinical psychological evaluation in elderly men with prostatic hypertrophy in treatment with Dutasteride. 116
AB0823 TRABECULAR BONE SCORE AT LUMBAR SPINE IS ASSOCIATED WITH QUANTITATIVE ULTRASOUND MEASUREMENTS AT PHALANGEAL SITE IN BREAST CANCER SURVIVORS RECEIVING AROMATASE INHIBITORS 115
Association between anxiety levels and osteoporosis in postmenopausal women. 114
Recombinant erythropoietin and hypertension 112
Amylasemia in uremics: a complex interpretation 112
ANXIETY SEVERITY AS A PREDICTOR OF OSTEOPOROSIS 112
Frailty modifications and prognostic impact in older patients admitted in acute care 111
Vitamin D and bone mineral density changes in postmenopausal women treated with strontium ranelate 110
Cardiovascular effects of raloxifene hydrochloride 109
FRAGILITÀ E PROFILO LIPIDICO IN UN GRUPPO DI PAZIENTI ANZIANI OSPEDALIZZATI 109
Role of genetic pattern on bone mineral density in thalassemic patients 106
SCLEROSTIN LEVELS IN TYPE 1 DIABETES MELLITUS: GENEDER DIFFERENCES AND ASSOCIATION WITH CLINICAL FEATURES 106
Effects of genistein and hormone-replacement therapy on bone loss in early postmenopausal women: A randomized double-blind placebo-controlled study 106
SCLEROSTIN AND DICKKOPF-1 LEVELS IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 105
EFFECTS OF DENOSUMAB ON QUANTITATIVE ULTRASOUND AND DUAL-ENERGY X-RAY ABSORPTIOMETRY MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 105
Cognitive impulsivity is associated with bone mineral density and history of falls in postmenopausal women. 104
WNT/beta-CATENIN AND RANK/RANKL/OPG SIGNALLING MODULATES EFFECTS OF PULSED ELECTROMAGNETIC FIELDS ON BONE IN WOMEN WITH POSTMENOPAUSAL OSTEOPOROSIS 104
Phalangeal quantitative ultrasound to investigate bone changes in aromatase inhibitor-treated breast cancer women receiving denosumab 103
Strontium ranelate improves bone mineral density in thalassemia major related osteoporosis and reduces sclerostin levels 103
Phalangeal quantitative ultrasound detects changes of bone status in aromatase inhibitor-treated breast cancer women. 103
A CASE OF OSTEOPOROTIC FRACTURES IN WOLFRAM SYNDROME 102
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 102
Handgrip and phalangeal ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis 101
INCIDENCE OF HYPOCALCEMIA AND HYPERCALCEMIA IN ELDERLY HOSPITALIZED PATIENTS 101
Deficit multiplo di AcilCoA deidrogenasi ad esordio tardivo. Descrizione di un caso clinico. 101
EFFECTS OF DENOSUMAB ON QUATITATIVE ULTRASOUND AND DXA MEASUREMENTS IN AROMATASE INHIBITOR-TREATED BREAST CANCER WOMEN 101
Bone health in Duchenne muscular dystrophy: clinical and biochemical correlates 101
TRABECULAR BONE SCORE IS PREDICTED BY PHALANGEAL QUANTITATIVE ULTRASOUND IN BREAST CANCER POSTMENOPAUSAL WOMEN RECEIVING AROMATASE INHIBITORS 100
BONE INVOLVEMENT IN DUCHENNE MUSCULAR DYSTROPHY 100
Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation 99
Teriparatide (rhPTH 1-34) in Duchenne Muscular Dystrophy related osteoporosis: a case report 99
SCLEROSTIN AND DICKKOPF-1 IN PREGNANT WOMEN WITH GESTATIONAL DIABETES 99
Pain in Osteoporosis: From Pathophysiology to Therapeutic Approach 99
EFFETTO CODA DI ALENDRONATO SULLA DENSITÀ MINERALE OSSEA IN DONNE CON OSTEOPOROSI POSTMENOPAUSALE: POSSIBILE RUOLO DELLA VITAMINA D 99
Osteoporosis and beta-thalassemia major: Role of the IGF- I/IGFBP-III axis 98
Fracture risk assessment in postmenopausal women referred to an Italian center for osteoporosis: a single day experience in Messina. 98
SCLEROSTIN AND DICKKOPF-1 CORRELATE WITH VASCULAR CALCIFICATIONS IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 98
VALUTAZIONE NEUROPSICOLOGICA IN SOGGETTI ANZIANI AFFETTI DA IPERTROFIA PROSTATICA BENIGNA IN TRATTAMENTO CON DUTASTERIDE 98
Cognitive impulsivity is associated with bone mineral density in postmenopausal women evaluated for osteoporosis. 98
HANDGRIP STRENGHT AND PHALANGEAL QUANTITATIVE ULTRASOUND IN THE FRACTURE RISK ASSESSMENT OF POSTMENOPAUSAL WOMEN 97
Effects of teriparatide on bone mineral density and quality of life in Duchenne muscular dystrophy related osteoporosis: a case report 97
Pulsed electromagnetic fields modulate sclerostin levels in women with postmenopausal osteoporosis 97
Impact of Premorbid IQ and Cognitive Reserve on Clinical and Functional Outcomes in Elderly Outpatients 97
Phalangeal quantitative ultrasound and metabolic control in premenopausal women with type 1 diabetes mellitus 96
Vitamin D modulates bmd gain in postmenopausal women treated with strontium ranelate 96
Effect of long-term treatment with Raloxifene on mammary density in postmenopausal women. 95
Are Physicians Ready to Prevent Osteoporotic Fractures in Hemodialysis Patients? 95
Vitamin D status is associated with anxiety levels in postmenopausal women evaluated for osteoporosis 95
Preventing bone loss during androgen deprivation therapy for prostate cancer: Early experience with neridronate. EUROPEAN UROLOGY, vol. 47; p. 575 - 581 94
BONE MINERAL DENSITY MODIFICATIONS IN ACCORDANCE TO VITAMIN D STATUS IN POSTMENOPAUSAL WOMEN TREATED WITH STRONTIUM RANELATE 94
In thyroxine-replaced hypothyroid postmenopausal women under simultaneous calcium supplementation, switch to oral liquid or softgel capsule L-thyroxine ensures lower serum TSH levels and favorable effects on blood pressure, total cholesterolemia and glycemia 94
Quality of life in postmenopausal women: Which role for vitamin D? 94
A single bone lesion in a man with prostate cancer: a case report of Paget’s disease of bone 93
L'azione di un bolo di rHu-EPO sul flusso muscolare di soggetti uremici 92
Sclerostin in type 1 diabetes mellitus: gender differences and associations with clinical features, bone mass and metabolism 92
HANDGRIP STRENGTH TO DISCRIMINATE HIGH FRACTURE RISK IN TYPE 2 DIABETES MELLITUS PATIENTS 92
Denosumab Inhibition of RANKL and Insulin Resistance in Postmenopausal Women with Osteoporosis 92
Handgrip and phalangeal quantitative ultrasound are predictive of fracture risk in postmenopausal women screened for osteoporosis. 91
Health related quality of life and anxiety in patients with Type 2 Diabetes Mellitus 91
Randomized, double-blind, placebo-controlled study on effects of raloxifene and hormone replacement therapy on plasma NO concentrations, endothelin-1 levels, and endothelium-dependent vasodilation in postmenopausal women 90
Three-year effectiveness of intravenous pamidronate versus pamidronate plus slow-release sodium fluoride for postmenopausal osteoporosis 90
Corrigendum to “Fracture Risk in Type 2 Diabetes: Current Perspectives and Gender Differences” 90
Pulsed electromagnetic fields modulate bone metabolism via RANKL/OPG and Wnt/β-catenin pathways in women with postmenopausal osteoporosis: A pilot study 90
THE CIRCADIAN-RHYTHM OF ERYTHROPOIETIN IN SUBJECTS WITH PRE- TERMINAL UREMIA 89
Cognitive Impairment and Slow Gait Speed in Elderly Outpatients with Arterial Hypertension: The Effect of Blood Pressure Values 89
Calcifediol improves lipid profile in atorvastatin treated postmenopausal women 89
Is erythropoietin-induced hypertension a phenomenon due to the intracellular Ca++ mobilisation? 88
VASCULAR CALCIFICATIONS ARE RELATED TO SCLEROSTIN AND DICKKOPF-1 IN NON-DIALYSIS CHRONIC KIDNEY DISEASE 88
Totale 11.172
Categoria #
all - tutte 65.579
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 65.579


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021411 0 0 0 0 0 93 34 45 17 111 59 52
2021/20221.526 13 194 19 58 39 16 153 45 160 246 133 450
2022/20233.460 256 349 165 241 304 324 33 190 1.428 22 104 44
2023/2024923 67 137 43 99 66 200 36 90 6 20 17 142
2024/20254.005 64 74 68 259 216 99 128 784 991 298 351 673
2025/20264.167 618 878 749 800 998 124 0 0 0 0 0 0
Totale 17.041